| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 10.169 | 22.001 | 27.693 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | 10.802 | 26.963 | 27.693 | 40.535 | 0 | 0 |
| Total Expenses - EUR | - | - | - | - | 15.390 | 32.335 | 23.821 | 3.892 | 0 | 7.720 |
| Gross Profit/Loss - EUR | - | - | - | - | -4.588 | -5.372 | 3.872 | 36.643 | 0 | -7.720 |
| Net Profit/Loss - EUR | - | - | - | - | -4.690 | -5.592 | 3.473 | 36.643 | 0 | -7.720 |
| Employees | - | - | - | - | 3 | 4 | 4 | 0 | 0 | 0 |
Check the financial reports for the company - Lab Med Dr Moldovan Claudia S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 38.762 | 30.091 | 29.424 | 25.623 | 25.546 | 17.686 |
| Current Assets | - | - | - | - | 2.318 | 4.382 | 4.722 | 4.553 | 4.539 | 4.504 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 552 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | 1.766 | 4.382 | 4.722 | 4.553 | 4.539 | 4.504 |
| Shareholders Funds | - | - | - | - | -4.648 | -10.152 | -6.453 | 30.169 | 30.078 | 22.189 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 3.604 | 3.299 | 190 | 7 | 7 | 0 |
| Income in Advance | - | - | - | - | 42.125 | 41.326 | 40.410 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Lab Med Dr Moldovan Claudia S.r.l.